Comparison of DWI and 18F-FDG PET/CT for assessing preoperative N-staging in gastric cancer: evidence from a meta-analysis
- PMID: 29137440
- PMCID: PMC5663612
- DOI: 10.18632/oncotarget.21055
Comparison of DWI and 18F-FDG PET/CT for assessing preoperative N-staging in gastric cancer: evidence from a meta-analysis
Abstract
The diagnostic values of diffusion weighted imaging (DWI) and 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) for N-staging of gastric cancer (GC) were identified and compared. After a systematic search to identify relevant articles, meta-analysis was used to summarize the sensitivities, specificities, and areas under curves (AUCs) for DWI and PET/CT. To better understand the diagnostic utility of DWI and PET/CT for N-staging, the performance of multi-detector computed tomography (MDCT) was used as a reference. Fifteen studies were analyzed. The pooled sensitivity, specificity, and AUC with 95% confidence intervals of DWI were 0.79 (0.73-0.85), 0.69 (0.61-0.77), and 0.81 (0.77-0.84), respectively. For PET/CT, the corresponding values were 0.52 (0.39-0.64), 0.88 (0.61-0.97), and 0.66 (0.62-0.70), respectively. Comparison of the two techniques revealed DWI had higher sensitivity and AUC, but no difference in specificity. DWI exhibited higher sensitivity but lower specificity than MDCT, and 18F-FDG PET/CT had lower sensitivity and equivalent specificity. Overall, DWI performed better than 18F-FDG PET/CT for preoperative N-staging in GC. When the efficacy of MDCT was taken as a reference, DWI represented a complementary imaging technique, while 18F-FDG PET/CT had limited utility for preoperative N-staging.
Keywords: diffusion weighted imaging; gastric cancer; lymph node staging; positron emission tomography/computed tomography.
Conflict of interest statement
CONFLICTS OF INTEREST None.
Figures
References
-
- Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin. 2017;67:7–30. https://doi.org/10.3322/caac.21387. - DOI - PubMed
-
- de Martel C, Forman D, Plummer M. Gastric cancer: epidemiology and risk factors. Gastroenterol Clin North Am. 2013;42:219–240. https://doi.org/10.1016/j.gtc.2013.01.003. - DOI - PubMed
-
- Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2014 (ver 4) Gastric Cancer. 2017;20:1–19. https://doi.org/10.1007/s10120-016-0622-4. - DOI - PMC - PubMed
-
- Ono H, Yao K, Fujishiro M, Oda I, Nimura S, Yahagi N, Iishi H, Oka M, Ajioka Y, Ichinose M, Matsui T. Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer. Dig Endosc. 2016;28:3–15. https://doi.org/10.1111/den.12518. - DOI - PubMed
-
- Eom BW, Yu JS, Ryu KW, Kook MC, Kim YI, Cho SJ, Lee JY, Kim CG, Choi IJ, Yoon HM, Kim YW. Optimal submucosal invasion of early gastric cancer for endoscopic resection. Ann Surg Oncol. 2015;22:1806–1812. https://doi.org/10.1245/s10434-014-4308-z. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
